These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7148138)

  • 21. [Surgical treatment of the Itsenko-Cushing syndrome accompanying an adrenal cortex neoplasm].
    Nechaĭ AI; Trofimov VM; Kalashnikov SA; Savushkina AS
    Vestn Khir Im I I Grek; 1980 Jul; 125(7):18-24. PubMed ID: 7414887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
    Lecka A; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [O.p. DDD (lysodren) in treatment of adrenal cortex hyperfunction in childhood].
    Keller E; Willgerodt H; Teichmann B; Hoepffner W
    Kinderarztl Prax; 1981 Aug; 49(8):436-41. PubMed ID: 7289414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood levels of ACTH and cortisol in patients with Itsenko-Cushing disease treated with chloditan].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Probl Endokrinol (Mosk); 1976; 22(3):48-51. PubMed ID: 180519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functioning and nonfunctioning adrenocortical carcinoma: clinical presentation and therapeutic strategies.
    Demeure MJ; Somberg LB
    Surg Oncol Clin N Am; 1998 Oct; 7(4):791-805. PubMed ID: 9735134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renin-angiotensin-aldosterone system in patients with Itsenko-Cushing syndrome treated with chloditane and large doses of reserpine].
    Slavnov VN; Iakovlev AA; Komissarenko IV; Cheban AK; Rybakov SI
    Ter Arkh; 1980; 52(8):40-3. PubMed ID: 7020145
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
    Opitz M; Lettow E; Loppnow H; Grevel V
    Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anesthesia and postoperative management in surgery for adrenal cortex neoplasms in children. Apropos of 24 cases].
    Dubousset AM; Melin Y; Saint-Maurice JP
    Anesth Analg (Paris); 1978; 35(2):279-85. PubMed ID: 211878
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide.
    Scott RD
    Postgrad Med J; 1975 Jan; 51(591):35-7. PubMed ID: 1161676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant mitotane in adrenocortical carcinoma.
    Dickstein G; Shechner C; Nativ O
    N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
    [No Abstract]   [Full Text] [Related]  

  • 31. Mitotane therapy of adrenocortical carcinoma.
    Haak HR; van Seters AP; Moolenaar AJ
    N Engl J Med; 1990 Sep; 323(11):758. PubMed ID: 2388676
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cancer of the adrenal cortex treated by O,P"-DDD (author's transl)].
    Van Geertruyden J; De Myttenaere M; Corvilain J
    Acta Chir Belg; 1980; 79(4):299-302. PubMed ID: 7468032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Cushing's disease with op' DDD].
    Golik A; Rosenberg T; Gilboa Y
    Harefuah; 1975 Dec; 89(12):563-4. PubMed ID: 1218835
    [No Abstract]   [Full Text] [Related]  

  • 34. [Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use].
    Bricaire H; Luton JP
    Therapie; 1974; 29(5):645-58. PubMed ID: 4462221
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of Cushing's syndrome and adrenal cancer with O,p-DDD].
    Kinouchi T; Shimizu N; Ibayashi H; Demura H; Oshima H
    Horumon To Rinsho; 1982 Aug; 30(8):841-51. PubMed ID: 7139984
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of Cushing's syndrome with chloditane].
    Komissarenko IV
    Klin Med (Mosk); 1976 Sep; 54(9):122-7. PubMed ID: 1003908
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjuvant mitotane in adrenocortical carcinoma.
    Lee JE
    N Engl J Med; 2007 Sep; 357(12):1258; author reply 1259. PubMed ID: 17891836
    [No Abstract]   [Full Text] [Related]  

  • 38. [Virilizing adrenal carcinoma: exeresis and successful treatment with op'DDD].
    Capdevila Sánchez J; Pavía Sesma C; Vila Torres J; Valls Tolosa C; Albarrán Deogracias J
    An Esp Pediatr; 1993 Apr; 38(4):351-4. PubMed ID: 8480949
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.
    Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
    Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of adrenal cortical disease.
    Paulson DF
    Urol Clin North Am; 1977 Jun; 4(2):297-304. PubMed ID: 898415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.